Bellevue Life Sciences Acquisition Corp. Unit
BLACU
BLACU was delisted on the 14th of February, 2025.
3 hedge funds and large institutions have $61.3K invested in Bellevue Life Sciences Acquisition Corp. Unit in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
21% more capital invested
Capital invested by funds: $50.8K → $61.3K (+$10.6K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$5.67K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $55.6K | +$5.67K | +500 | +12% |
|
2
UBS Group
Zurich,
Switzerland
| $5.6K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $116 | – | – | – |
|
BLACU Hedge Fund Activity: Q4 2024 in Review
3 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q4 2024, worth a combined $61.3K — up 21% from $50.8K a quarter earlier.
Fund positioning in BLACU was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Clear Street, adding an estimated $5.67K.
- 3 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $61.3K of Bellevue Life Sciences Acquisition Corp. Unit stock for Q4 2024, up 21% quarter-over-quarter.
- 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q4 2024 and 0 closed out.
- The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q4 2024 was Clear Street, an estimated $5.67K added.
Based on aggregated 13F filings for Q4 2024.